림프부종 환자에서 림프신티그라피의 임상적 적용
Received: Mar 08, 2022; Accepted: Apr 01, 2022
Published Online: May 31, 2022
Abatract
Lymphoscintigraphy is a non-invasive imaging test that visualizes the functions of the lymphatic system by injecting a colloidal radiopharmaceutical having a relatively large particle size (15-100 nm) intradermally or subcutaneously. For lymphedema occurring after cancer treatment lymphoscintigraphy can be applied in 1) differential diagnosis of edema, 2) visualize the functional status and severity of the lymphedema in a qualitative and quantitative manner, 3) evaluate functional improvement of lymphatics after treatment, 4) predict and may guide the therapeutic effect of lymphedema treatment. In this review, we will introduce clinical application studies according to the indications of lymphoscintigraphy and discuss the technical considerations of lymphoscintigraphy.
Metrics
QR Code of this Article:
Related Articles
Lymphoscintigraphy in Lymphedema: Procedure and Interpretation Guideline by the Korean Society of Nuclear Medicine and Korean Society of Lymphedema Part II
Clin. Lymphology Lymphedema 2025;10(1):1-13.
Lymphoscintigraphy in Lymphedema: Procedure and Interpretation Guideline by the Korean Society of Nuclear Medicine and Korean Society of Lymphedema Part I
Clin. Lymphology Lymphedema 2024;9(2):39-44.
Venous Disease Related Lymphedema - Phlebolymphedema
Clin. Lymphology Lymphedema 2018;3(1):10-14.
Current Challenges and Future Directions in Lymphedema Diagnosis and Staging
Clin. Lymphology Lymphedema 2025;10(2):48-52.
Clinical Relevance of Normal and Abnomal Findings in Lymphoscintigraphy in Patients with Lymphedma
Clin. Lymphology Lymphedema 2024;9(2):22-27.
